This message was sent to ##Email##
|
|
|
|
|
Medical News Today
A 21-year-old man left paralyzed after a spinal cord injury has regained the use of his arms and hands, thanks to an experimental stem cell treatment performed by researchers from the Keck Medical Center at the University of Southern California. In March of this year, Kristopher (Kris) Boesen was involved in a car accident, in which he suffered severe trauma to his cervical spine that left him paralyzed from the neck down and unable to breathe without assistance.
READ MORE
HealthDay News
Researchers say they've discovered a cellular defect that may be common to all forms of Parkinson's disease.
The defect plays a major role in the die-off of a group of nerve cells whose loss is a hallmark of Parkinson's, according to the Stanford University team.
READ MORE
|
Promoted by
|
|
|
|
 |
Reuters
In 2013, the U.S. Centers for Disease Control and Prevention released estimates of how many people in the country die every year from antibiotic resistant infections: 23,000. The agency estimates that an additional 15,000 die annually from Clostridium difficile, an infection linked to long-term antibiotic use.
READ MORE
 |
|
The LIAISON® Treponema assay is your solution for automating syphilis testing. Improve sensitivity and specificity over RPR screening using our fully-automated LIAISON® XL platform. The LIAISON® Treponema assay detects both IgG and IgM antibody response to T. pallidum infections. Visit www.diasorin.com for more information.
|
|
American Physiological Society via Lab Manager
Researchers have isolated an enzyme from bacteria present in human saliva that has potential as a therapy for celiac disease, an autoimmune disorder that causes severe digestive and other health problems among sufferers when they consume gluten. An estimated 3 million people in the U.S. have celiac disease.
READ MORE
Albert Einstein College of Medicine via Infection Control Today
In research published online Sept. 8 in Science, a team of scientists describe a new therapeutic strategy to target a hidden Achilles' heel shared by all known types of Ebola virus. Two antibodies developed with this strategy blocked the invasion of human cells by all five Ebola viruses, and one of them protected mice exposed to lethal doses of Ebola Zaire and Sudan, the two most dangerous.
READ MORE
 |
|
AMT certified members are competent and passionate and committed to providing quality healthcare.
|
|
Agency for Science, Technology and Research via Phys.org
The renewal of cells in a healthy stomach is being studied by Agency for Science, Technology and Research researchers through a multidisciplinary approach that combines cell lineage tracing experiments and mathematical modeling. The models provide a valuable baseline for studying gastric diseases, and the approach can be used to investigate the developmental dynamics of other organs.
READ MORE
University of Illinois at Urbana-Champaign via ScienceDaily
In breakthrough research on breast cancer, a team discovered that higher levels of the nuclear transport gene XPO1 indicate when a patient is likely to be resistant to the popular drug tamoxifen.
However, combining tamoxifen with the drug selinexor, which inhibits the activity of XPO1, enhances patients' sensitivity to tamoxifen and prevents breast tumors from recurring, the researchers reported in a paper published online by the journal Molecular Endocrinology.
READ MORE
 |
|
Give your health system access to CLSI’s full library of documents, including EP23, the best source for IQCP guidance.
Visit http://clsi.org/health-system to learn more.
|
|
Case Western Reserve University
The number of tubules in tumors may predict which women with estrogen receptor positive (ER+) breast cancer will benefit from hormone therapy alone and which require chemotherapy. Tubules represent the tumor's vasculature, providing tumors with oxygen and nutrition. The more of them there are, the more likely a patient will need chemotherapy.
READ MORE
DARK Daily
For nearly 20 years, researchers have heralded microfluidic devices, paper-based diagnostics and other lab-on-a-chip technologies as ways for medical laboratory scientists, pathologists and other medical diagnostic professionals to reduce the time and costs of clinical laboratory services. With the promise of obtaining results in just minutes without the need for extensive training, these point-of-care tests and devices create big buzz with each new design.
READ MORE
|
|
 |
|
Discover YES. With LGC Maine Standards’ Yearly Evaluation Subscription program featuring VALIDATE®, you’ll never worry about challenging your instrument’s full Analytical Measurement Range (AMR). VALIDATE® offers multiple product configurations meeting the needs of the many instrument systems available, virtually eliminating dilutions while maximizing reportable ranges. Visit www.mainestandards.com or call 1-800-377-9684 to learn more. |
|
|
|
|
 |
|
ZeptoMetrix Corporation (ZMC) is an Industry leader and innovator identified with quality, reliable and trusted Products and Services for Infectious Disease Diagnostic Development. From assay conception to launch, our Scientific and Operational Teams provide our Customers with cohesive, inventive and cost effective solutions.
Learn More
|
|
|
|
International AIDS Vaccine Initiative via ScienceDaily
New approaches that could spur the human body to produce HIV-blocking antibodies have been successful in mice mimicking the human immune system, according to five new studies.
READ MORE
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
